• Cardiology, Diabetes & Nephrology
    • Cardiology, Diabetes & Nephrology – London
    • Cardiology, Diabetes & Nephrology – Brazil
    • Cardiology, Diabetes & Nephrology – Canada
    • Cardiology, Diabetes & Nephrology – USA
    • Hatter Horizon Series
    • The 18th Malvern Diabetic Foot Conference
    • Previous Events
      • CDNATL 2019 – London
      • CDNATL 2019 – Brazil
      • CDNATL 2018
      • CDNATL 2017
      • CDNATL 2016
      • CDNATL 2015
      • CDNATL 2014
      • CDATL 2013
      • CDATL 2012
      • NATL 2012
      • CDATL 2011
      • CDATL 2010
      • NATL 2010
      • CATL 2009
      • NATL 2009
  • Cell Therapy
    • Cell Therapy at the Limits 2021
  • Oncology
    • Previous Events
      • Accelerating Cancer Immunotherapy 2017
      • OATL 2016
      • OATL 2015
      • OATL 2014
      • OATL 2012
      • OATL 2011
      • OATL 2010
      • UCL Frontiers of Oncology 2019
        • Haematology
        • Melanoma
        • Urology
        • Women’s Health
        • Lung Cancer
        • Gastrointestinal Oncology
        • Paediatric Oncology
        • Supporters
  • Multiple Sclerosis
    • Multiple Sclerosis at the Limits 2021
    • Multiple Sclerosis Nurses at the Limits 2021
    • Previous Events
      • Multiple Sclerosis Nurses at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2019
      • MSATL 2018: Introduction
      • MSATL 2017: Introduction
  • About
    • Academic Founders
    • Independence
    • The Lancet
    • Support & Sponsorship
    • Delegate Invitations
  • Supporters
  • Archive
    • CDNATL 2019 – London
    • CDNATL 2019 – Brazil
    • Multiple Sclerosis at the Limits 2018
    • Multiple Sclerosis at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2019
    • Hatter Horizon Series
      • Horizon GP Programme 2019
      • Hatter Horizon Series 2019
      • Hatter Horizon Series 2018
      • Hatter Horizon Series 2017
    • Cardiology, Diabetes & Nephrology at the Limits 2018
    • Accelerating Cancer Immunotherapy 2017
    • Oncology at the Limits 2017

Dr Gordon Mazibrada

Dr Gordon Mazibrada is a Consultant Neurologist at the Queen Elizabeth Hospital in Birmingham and Good Hope Hospital in Sutton Coldfield. He has a special interest in multiple sclerosis and neuroinflammatory disorders. He completed his neurological training in 2006. His research was at The National Hospital for Neurology and Neurosurgery in London. He has extensive experience in the use of disease modifying drugs in multiple sclerosis. He runs MS Specialist Clinics at the Queen Elizabeth Hospital in Birmingham which is a regional multiple sclerosis referral centre covering a population of about 4.5 million.  He is a principal investigator in several multicentre clinical trials in multiple sclerosis at The Queen Elizabeth Hospital.

« Professor Andrei Sposito
Dr Trevor Pickersgill »

Cardiology, Diabetes & Nephrology at the Limits Canada
Wednesday, 3 & Thursday, 4 March 2021, Virtual Meeting

Cardiology, Diabetes & Nephrology at the Limits 2021
Monday, 12 - Tuesday, 13 April 2021, London, UK

The 18th Malvern Diabetic Foot Conference
Wednesday, 12 – Friday, 14 May 2021, Malvern, UK

Hatter Horizon GP Meeting
Wednesday, 19 May 2021
London, UK

Hatter Horizon Series
Friday, 21 May 2021
London, UK

Multiple Sclerosis Nurses
at the Limits

Friday, 4 & Saturday, 5 June 2021, London, UK

Multiple Sclerosis at the Limits
Thursday, 24 & Friday, 25 June 2021, London, UK

Cardiology, Diabetes & Nephrology at the Limits Brazil
Friday, 16 - Saturday, 17 July 2021, São Paulo, Brazil

Cell Therapy at the Limits 2021
Wednesday, 21 & Thursday, 22 July 2021, London, UK

Policy links

  • Medical Disclaimer
  • Disclosure
  • E-mail Policy
  • Privacy Policy
  • Anti-spam Policy
  • Disclaimer
  • External Links Policy
  • Terms of use
  • Contact
  • The Lancet
  • UCL
  • UCT
  • Brigham & Women’s Hospital
  • The University of Campinas
© 2020 At the Limits Ltd.
This site uses cookies More info